Yes, all-cause cause mortality is higher among TAVR patients with a very low baseline gradient, but the difference is almost entirely due to those patients presenting with more comorbidities.
Yes, all-cause cause mortality is higher among TAVR patients with a very low baseline gradient, but the difference is almost entirely due to those patients presenting with more comorbidities.